Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Helvepharm Ag
02 7Orion Corporation
03 51A Pharma Gmbh
04 32Care4 Aps
05 23M Health Care Ltd
06 1Ababor Pharmaceuticals Sl
07 2Abacus Medicine A/S
08 2Acino Ag
09 9Actavis Group Ptc Ehf.
10 8Almirall Sa
11 2Amw Gmbh
12 4Arrow Aps
13 4Aurobindo Laboratories Slu
14 1Cinfa Laboratories Sa
15 5Combix Laboratories Slu
16 5Ebb Medical Ab
17 5Elpen Pharmaceutical Co. Inc
18 5Farmalider Sa
19 1Galenicum Derma Sl
20 5Hexal Ag
21 5Kern Pharma Sl
22 9Krka Dd Novo Mesto
23 8Krka Dd, Novo Mesto
24 2Luye Pharma Switzerland Ag
25 1Medartuum Ab
26 3Mepha Pharma Ag
27 6Mylan Ab
28 4Normon Laboratories Sa
29 8Novartis Europharm Limited
30 8Novartis Pharma Schweiz Ag
31 7Orifarm Generics A/S
32 4Ratiopharm Gmbh
33 3Sandoz A/S
34 15Sandoz Gmbh
35 3Sandoz Pharmaceuticals Ag
36 9Stada Pharmaceuticals Ag
37 4Stada Sl Laboratory
38 5Synthon Bv
39 3Teva Bv
40 4Teva Pharma Bv
41 1Torrefarma Sl
42 1Vegal Farmaceutica Sl
43 2Vir Sa Chemical And Pharmaceutical Industry
44 5World Medicine Ilac San ve tic LTD STl
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 15/01/2020
Application Number : 20181221000018
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rivastigmine Zentiva Patch h
Dosage Form : Transdermal Patch
Dosage Strength : 13.3mg/24hours
Packaging :
Approval Date : 27/03/2014
Application Number : 62917
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 4.6mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000046
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rivastor
Dosage Form : Transdermal Patch
Dosage Strength : 9.5mg/24hours
Packaging :
Approval Date : 13/06/2013
Application Number : 20110507000053
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 1.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000025
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000049
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength : 4.5mg
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000056
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Rivastigmine Hydrogen Tartrate
Brand Name : Rivastigmine Orion
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 03/07/2009
Application Number : 20080517000063
Regulatory Info : Approved
Registration Country : Sweden
